×
App Icon
The Standard e-Paper
Kenya's Bold Newspaper
★★★★ - on Play Store
Download Now

Alarm as experts warn baby syrup can cause liver problems

Panadol Baby and Infant Suspension
Panadol Baby and Infant Suspension by GSK   photo: courtesy

The recall of Panadol Baby and Infant Suspension by GlaxoSmithKline (GSK) weeks ago has triggered an alarm. Medical practitioners have warned that prolonged use of wrong dosage of syrups could have serious health implications. The Pharmaceutical Society of Kenya (PSK) President, Dr Paul Mwaniki, raised the red flag last month and revealed that the recalled drug was still in the market, despite complaints raised on dosage and calibrations of syringes packed for its administration.

Dr Mwaniki said that though there were no major issues with the Panadol suspension, the wrong dosage was subjecting babies to high levels of paracetamol that could cause liver complications in the long-term.

Get Full Access for Ksh299/Week
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in